Indeed, an IL13Rα2 D1 peptide located at the IL-13 binding site [25] showed strong inhibition capacity for the IL-13/IL13Rα2 signaling cascade in metastatic CRC and glioblastoma [26]. The gene discussed is IL13; the disease is glioblastoma.